HK1247150A1 - 用聲學混合自動造粒 - Google Patents

用聲學混合自動造粒

Info

Publication number
HK1247150A1
HK1247150A1 HK18106654.4A HK18106654A HK1247150A1 HK 1247150 A1 HK1247150 A1 HK 1247150A1 HK 18106654 A HK18106654 A HK 18106654A HK 1247150 A1 HK1247150 A1 HK 1247150A1
Authority
HK
Hong Kong
Prior art keywords
granulation
auto
acoustic mixing
acoustic
mixing
Prior art date
Application number
HK18106654.4A
Other languages
English (en)
Inventor
Ping Gao
Raimundo Ho
Jayanthy Jayanth
Samrat Mukherjee
Katherine E Peterson
John C Strong
Ping Tong
Geoff G Zhang
Original Assignee
Abbvie Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbvie Inc filed Critical Abbvie Inc
Publication of HK1247150A1 publication Critical patent/HK1247150A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F31/00—Mixers with shaking, oscillating, or vibrating mechanisms
    • B01F31/80—Mixing by means of high-frequency vibrations above one kHz, e.g. ultrasonic vibrations
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F2101/00—Mixing characterised by the nature of the mixed materials or by the application field
    • B01F2101/22—Mixing of ingredients for pharmaceutical or medical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Mixers With Rotating Receptacles And Mixers With Vibration Mechanisms (AREA)
HK18106654.4A 2015-07-07 2018-05-23 用聲學混合自動造粒 HK1247150A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562189677P 2015-07-07 2015-07-07
PCT/US2016/041275 WO2017007895A1 (en) 2015-07-07 2016-07-07 Acoustic mixing for auto granulation

Publications (1)

Publication Number Publication Date
HK1247150A1 true HK1247150A1 (zh) 2018-09-21

Family

ID=56507840

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18106654.4A HK1247150A1 (zh) 2015-07-07 2018-05-23 用聲學混合自動造粒

Country Status (7)

Country Link
US (2) US9949973B2 (zh)
EP (1) EP3319718A1 (zh)
JP (1) JP2018520868A (zh)
CA (1) CA2991315A1 (zh)
HK (1) HK1247150A1 (zh)
MX (1) MX2018000221A (zh)
WO (1) WO2017007895A1 (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3388421B1 (en) 2017-04-13 2019-12-04 Sandoz AG Acid addition salts of an orally available gonadotropin-releasing hormone receptor antagonist
CA3059815C (en) 2017-04-12 2020-10-27 Sandoz Ag Acid addition salts of an orally available gonadotropin-releasing hormone receptor antagonist, elagolix
ES2770132T3 (es) 2017-04-13 2020-06-30 Sandoz Ag Dispersión sólida amorfa de un antagonista del receptor de la hormona liberadora de gonadotropina disponible por vía oral
TW201912157A (zh) * 2017-08-18 2019-04-01 美商艾伯維有限公司 治療子宮內膜異位症、子宮纖維瘤、多囊性卵巢症候群及子宮腺肌症之固體醫藥調配物
AU2018317472A1 (en) * 2017-08-18 2020-03-05 Abbvie Inc. Pharmaceutical formulations for treating endometriosis, uterine fibroids, polycystic ovary syndrome or adenomyosis
JP2021531236A (ja) 2018-04-19 2021-11-18 アッヴィ・インコーポレイテッド 重度の月経出血を治療する方法
IL310267A (en) 2018-07-23 2024-03-01 Abbvie Inc Sodium Alagolix Compositions and Processes
WO2020043763A1 (en) 2018-08-31 2020-03-05 Sandoz Ag Process for preparing elagolix formulations and dosage forms comprising the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3275787A (en) 1963-12-30 1966-09-27 Gen Electric Process and apparatus for producing particles by electron melting and ultrasonic agitation
EP2042232A1 (en) * 2007-07-25 2009-04-01 Symyx Technologies, Inc. Systems and methods for mixing materials
US8215822B2 (en) * 2007-12-28 2012-07-10 Kimberly-Clark Worldwide, Inc. Ultrasonic treatment chamber for preparing antimicrobial formulations
WO2014078258A1 (en) * 2012-11-16 2014-05-22 Merck Sharp & Dohme Corp. Process for making agglomerates using acoustic mixing technology

Also Published As

Publication number Publication date
US20180235962A1 (en) 2018-08-23
MX2018000221A (es) 2018-03-08
JP2018520868A (ja) 2018-08-02
CA2991315A1 (en) 2017-01-12
US20170007600A1 (en) 2017-01-12
EP3319718A1 (en) 2018-05-16
US9949973B2 (en) 2018-04-24
WO2017007895A1 (en) 2017-01-12

Similar Documents

Publication Publication Date Title
EP3141169A4 (en) Mixer
HK1252089A1 (zh) 固體形式
HK1247150A1 (zh) 用聲學混合自動造粒
AU359340S (en) Mixer
GB201510019D0 (en) Compounds
AU357894S (en) Mixer
GB201514754D0 (en) Compounds
PL3238826T3 (pl) Granulator
GB201514751D0 (en) Compounds
GB201508747D0 (en) Compounds
EP3395436C0 (en) MICROREACTOR
PL3364753T5 (pl) Wóz paszowy
HK1252614A1 (zh) 二環化合物
GB201608319D0 (en) Mixer unit
GB201508864D0 (en) Compounds
HK1216364A1 (zh) 音頻混頻器
GB201510493D0 (en) Compounds
EP3236582A4 (en) Mixer module
GB201508857D0 (en) Compounds
GB201503926D0 (en) Compounds
GB201501115D0 (en) Compounds
GB201508373D0 (en) Auto start GPS app
GB201516680D0 (en) Assay for methyltrasferase
HK1205858A2 (zh) 二合隔水攪拌器
AU364589S (en) Trailer